Search titles, summaries, tags and full article text.
One round of mRNA display is a population process shaped by library design, translation, fusion formation, target selection, counter-selection, washing, recovery, amplification, and NGS.
mRNA display combines genotype–phenotype linkage, cell-free translation, genetic code reprogramming, noncanonical amino-acid incorporation, macrocyclization, and iterative selection in one traceable discovery system.
Unnatural amino acids are not merely a simple expansion of the natural amino acid alphabet; rather, they are design variables capable of altering backbone geometry, side-chain interactions, conformational preferences, and synthetic routes. Their rational application requires starting from the specific bottlenecks of existing peptides and making multi-objective trade-offs among activity, stability, permeability, solubility, and manufacturability.
Learn when a linear peptide should be cyclized and how cyclic peptide design compares lactam, disulfide, and head-to-tail cyclization strategies while accounting for AI-guided structural review, synthesizability, and practical peptide synthesis.
AI peptide optimization can balance stability and solubility around an existing parent peptide. Learn how NCAAs, D-amino acids, N-methylation, cyclization, synthesizability, and practical peptide synthesis shape candidate selection.
AI peptide design can generate candidates quickly, but biological scores do not guarantee practical synthesis or purification. This article explains how peptide synthesizability, SPPS, noncanonical amino acids, cyclic peptides, purification difficulty, and practical peptide synthesis should shape candidate selection.
mRNA display uses a puromycin-mediated covalent linkage so that each peptide carries its own sequence identity, enabling iterative selection from libraries on the order of 10¹²–10¹³ molecules and supporting cyclic-peptide, NCAA and data-driven discovery.
Peptide salt forms can affect solubility, biocompatibility, actual content, and performance in certain experimental systems. This article introduces the differences among TFA Salt, Acetate Salt, HCl Salt, and Free Form, and explains how to select an appropriate salt form for different application scenarios.
Peptide solubility is closely related to sequence composition, net charge, hydrophobicity, length, cyclization, and chemical modifications. This article introduces commonly used dissolution strategies for different types of peptides to help customers select appropriate solvents based on the sequence.
Cosmetic peptides can be classified by mechanism of action into categories such as signal peptides, neurotransmitter-modulating peptides, carrier peptides, enzyme-inhibiting peptides, and repair peptides. This article introduces the functional characteristics of different types of cosmetic peptides and uses conopeptides and copper peptides as representative case studies to illustrate their applications in high-end skin care products.
In clinical laboratories, macromolecule testing has long been dominated by immunoassays, whereas small-molecule testing is increasingly shifting toward LC-MS/MS. The division of roles between the two types of technologies stems from differences in the analytes themselves: proteins and peptides have multiple epitopes and are well suited to dual-antibody sandwich recognition; small molecules are compact and have many structural analogs, making competitive immunoassays more susceptible to cross-reactivity, and therefore better suited to mass spectrometry platforms that rely on recognition of molecular structural features.
N-methyl amino acids can improve the membrane permeability, metabolic stability, and developability of peptide drugs by modulating the number of hydrogen-bond donors, polar surface area, conformational preferences, and modes of protease recognition, making them important tools in the design of cyclic peptides and oral peptide drugs.